Money on Vaccines
We cannot blindly accept participation in a clinical trial of a novel gene-based therapy.
Reviewing what went right and wrong over the past twelve months helps us make better decisions for the year ahead.
It's customary at this time of year to revisit some of the financial discussions we have had during the previous twelve months.
Doing so provides an opportunity to see where things went as anticipated and where some rethinking might be required.
These conversations are not for everyone as we all have unique circumstances and different resources available.
However, one of our recommended actions was readily available to all and has stood to benefit everyone who took it up.
Join 50K+ readers of the no spin Weekly Dose of Common Sense email. It's FREE and published every Wednesday since 2009